[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[Dotgnu-libs-devel] Do it right now do not miss this great opportunity!
[Dotgnu-libs-devel] Do it right now do not miss this great opportunity! Fresh news
Mon, 22 Jan 2007 21:01:17 -0060
Grab Human BIOSYSTEMS INC. (HBSC.OB) stock today.
THE ALERT IS ON! AND IT IS GOING TO EXPLODE.
Monday will be the day when your gains will be really EXTENDED.
It's getting growth almost every hour! So you can triple your balance any time.
We are sure thet you had not moment like that before.
Friday price: JAN 18 - $0.08
On monday 22 January it will - 0.13$ at least and 0.20$ at most (not bad for a
Inform your brokers in order they take it now.
Do not miss your chance.MORE THAN 35% EVERY DAY!
HBSC just released this news.
U.S. Patent Office to Grant Human BioSystems its Fifth Patent, "Compositions,
Methods and Apparatuses for Preserving Platelets"
Monday January 22, 7:00 am ET
PALO ALTO, CALIFORNIA--(MARKET WIRE)--Jan 22, 2007 -- Human BioSystems (HBS)
(OTC BB:HBSC.OB - News), developer of preservation platforms for organs, blood
platelets and other biomaterials, announced today that the U.S. Patent Office
has allowed HBS' patent application for platelet preservation entitled
"Compositions, Methods and Apparatuses for Preserving Platelets." A patent
number is expected to be issued in the near future.
HBS has been granted four previous patents related to organ, platelet and
biological material preservation. Including the patent to be issued, HBS'
patent portfolio is as follows:
1. Methods and Apparatus for Preserving Biological Materials - U.S. Patent #
2. Methods and Apparatuses for Preserving Platelets - U.S. Patent # 6,828,090
3. Methods and Solutions for Storing Donor Organs - U.S. Patent # 7,029,839
4. Preservation of Blood Platelets with Citrate - U.S. Patent # 7,083,910
5. Compositions, Methods and Apparatuses for Preserving Platelets - U.S. Patent
number to be issued
"All of the patents we have received thus far serve to strengthen our
intellectual property protection as we progress toward commercializing our
technologies and bringing them to market," explained Dr. David Winter,
President of Human BioSystems.
The latest patent to be awarded is among four patents that relate to the
preservation of blood platelets, a blood component critical to cancer patients
that have undergone chemotherapy/radiation treatments. Platelet infusions are
necessary for a period of time following such cancer treatments to maintain
adequate platelet counts. The lack of platelets could increase the chances of
"HBS hopes to extend the preservation time of platelets beyond current
standards while maintaining quality and safety by utilizing patented cooling
methods not achieved by others thus far in the commercial blood banking
industry. If successful, this could result in hundreds of millions of dollars
in savings to blood centers and hospitals worldwide," concluded Dr. Winter.
HBS is headquartered in Palo Alto, California with research facilities in
Certain statements contained herein are "forward-looking'' statements (as such
term is defined in the Private Securities Litigation Reform Act of 1995).
Because such statements include risks and uncertainties, actual results may
differ materially from those expressed or implied by such forward-looking
statements. Factors that could cause results to differ materially from those
expressed or implied by such forward-looking statements include, but are not
limited to, results from ongoing research and development as well as clinical
studies, failure to obtain regulatory approval for the Company's products, if
required, failure to develop a product based on the Company's technology,
failure of any such products to compete effectively with existing products, the
inability to find a strategic partner or to consummate a relationship with a
potential strategic partner on acceptable terms, the effectiveness of
protection of the Company's intellectual property, and other factors discussed
in filings made by the Company with the Securities and Exchange Commission.
TAKE THIS EXCITING HBSC.OB right now.
|[Prev in Thread]
||[Next in Thread]|
- [Dotgnu-libs-devel] Do it right now do not miss this great opportunity! Fresh news,
Leticia Kurtz <=